Really Col... You need to read the text a bit more carefully
“We are very pleased with FDA’s feedback that the presented results from our pivotal study of rexlemestrocel-L in end-stage HFrEF patients with LVADs MAY support an accelerated approval,” said Mesoblast CEO Dr. Silviu Itescu. “We intend to request a pre-Biologics License Application (BLA) meeting to discuss data presentation, timing and FDA expectations for an accelerated approval filing.”
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-438
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.035(2.97%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.13 | $2.387M | 2.080M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 52037 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 59734 | 12 |
View Market Depth
| Last trade - 12.06pm 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |